David S. Chernow has been the CEO of Select Medical Holdings since 2010. He brings a wealth of experience from previous roles, including President and CEO of Oncure Medical Corp. and a leadership position at JA Worldwide, the largest nonprofit...

David S. Chernow has been the CEO of Select Medical Holdings since 2010. He brings a wealth of experience from previous roles, including President and CEO of Oncure Medical Corp. and a leadership position at JA Worldwide, the largest nonprofit organization focused on teaching kids about business. Under his leadership, Select Medical has made significant strides, reflected in his impressive compensation, which reached over $10 million in 2023. This number includes bonuses linked to the company’s strong performance metrics like return on equity. Chernow's leadership style emphasizes aligning executive interests with those of shareholders, which has been a key aspect of Select Medical's culture. Interestingly, he entered the company with a hefty stock award plan that includes the potential for shares to vest early in case of major changes within the company, ensuring that he is well-prepared for any situation. He utilizes company resources, such as aircraft, for both business and personal travel, reflecting the nature of executive life. David's long tenure and background in healthcare and education uniquely position him to drive Select Medical forward, navigating challenges while keeping a strong focus on strategic growth.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

S

David S. Chernow

CEO of Select Medical Holdings

Field of Expertise

Business & Management

Sector of Economy

Healthcare

CEO of Select Medical Holdings for

14 years 6 months (Sep 2010 - Present)

Previous Experience

President and CEO of Oncure Medical Corp., President and CEO of JA Worldwide

Rivals

Competitors/colleagues of David S. Chernow

Holdings

See how much did David S. Chernow make over time.

David S. Chernow holds a significant amount of stock in Select Medical, which peaked in value as he navigated the company to new heights during his tenure. In 2023, he was reported to have 250,000 shares that will vest gradually,...

David S. Chernow holds a significant amount of stock in Select Medical, which peaked in value as he navigated the company to new heights during his tenure. In 2023, he was reported to have 250,000 shares that will vest gradually, an indication of trust in the company’s long-term growth. In the past, he has seen fluctuations in his wealth based on stock performance, especially significant when he first joined the company with a large stock award. This strategy shows his commitment to the company's future and aligns his earnings with that of the shareholders. With a vested stock value of around $6.9 million as of last year, his financial future is closely tied to the company's performance, a classic move for CEOs looking to ensure they have skin in the game.

Mar 18, 2025

S

shares

SEM @ $16.91

Total Stock Sold

$17.82M

SEM

$17.82M

1,146,926 SEM shares

What if they kept their stock?

If David S. Chernow didn't sell their stock, today they would have:
Extra SEM1,146,926 shares worth $18.78M.
This is 5.34% and $952.27K more than what they got when they sold the stock.

Insider Trading

See recent insider trades of David S. Chernow.

SEM

230,000 shares

SEM

Apr 30, 2024

Received

SEM

250,000 shares

SEM

Aug 1, 2023

Received

SEM

$3.81M

SEM at $27.30/share

Feb 27, 2023

Sale

SEM

250,000 shares

SEM

Aug 1, 2022

Received

SEM

$5.04M

SEM at $36.14/share

Aug 9, 2021

Sale

SEM

200,000 shares

SEM

Aug 3, 2021

Received

SEM

$2.79M

SEM at $25.00/share

Nov 9, 2020

Sale

SEM

250,000 shares

SEM

Jul 28, 2020

Received

SEM

$630.75K

SEM at $19.44/share

Nov 1, 2019

Sale

SEM

$1.43M

SEM at $18.04/share

Oct 29, 2019

Sale

Compensation History

See how much did David S. Chernow make over time.

In 2023, David S. Chernow's total compensation was approximately $10.1 million, including a base salary of $995,000 and performance-based bonuses of over $1.8 million. This reflects his achievement in driving the company’s performance, particularly in return on equity and earnings per share. His previous year’s compensation was significantly lower, showcasing the ups and downs in executive earnings based on company results. The structure of his pay is designed to reward him not just for being at the helm, but for actual performance metrics that matter to the business's health. His compensation package is comprehensive, also considering benefits like a 401(k) match and personal perks including company aircraft usage, which underscores the level of responsibilities held by a CEO in this sector.

Year

2023

Total Compensation

$9.10M

Salary

$995.00K

Board Justification

The compensation philosophy is designed to reward contributions to the Company’s financial performance and provide overall compensation sufficient to attract and retain highly skilled NEOs, aligning their interests with those of stockholders.

Bonus

$1.89M

Board Justification

Based on the Company's performance metrics including return on equity and earnings per share, resulting in bonuses equaling 190% of target for each NEO participant.

Other

$340.77K

Board Justification

Includes 401(k) matching contributions, personal use of aircraft, dividends paid on unvested shares of restricted stock, and physical examination reimbursements.

Restricted Stock

$5.88M(250K common stock)

Board Justification

Restricted stock granted under the 2020 Equity Plan, which will vest in full in equal installments on each of the first three anniversaries of the date of grant beginning on August 1, 2024, subject to continued employment.

Performance Metrics

The performance metrics for determining the compensation included adjusted earnings per share and return on equity.